Status: current, Defined. Date: 31-Aug 2019. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3452741000168117 | Buprenorphine/Naloxone 11.4/2.9 (MPL) (buprenorphine 11.4 mg + naloxone 2.9 mg) sublingual tablet, 7 tablets (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3452751000168115 | Buprenorphine/Naloxone 11.4/2.9 (MPL) sublingual tablet, 7 | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Buprenorphine/Naloxone 11.4/2.9 (MPL) sublingual tablet, 7 | Is a | buprenorphine 11.4 mg + naloxone 2.9 mg sublingual tablet, 7 | true | Inferred relationship | Some | ||
| Buprenorphine/Naloxone 11.4/2.9 (MPL) sublingual tablet, 7 | Is a | trade product pack | true | Inferred relationship | Some | ||
| Buprenorphine/Naloxone 11.4/2.9 (MPL) sublingual tablet, 7 | has TPUU | Buprenorphine/Naloxone 11.4/2.9 (MPL) sublingual tablet | true | Inferred relationship | Some | 1 | |
| Buprenorphine/Naloxone 11.4/2.9 (MPL) sublingual tablet, 7 | has TP | Buprenorphine/Naloxone 11.4/2.9 (MPL) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Buprenorphine/Naloxone 11.4/2.9 (MPL) sublingual tablet, 7, blister pack | Is a | True | Buprenorphine/Naloxone 11.4/2.9 (MPL) sublingual tablet, 7 | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR